Staar Surgical price target lowered to $39 from $49 at BTIG
BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...
Staar Surgical (STAA) Receives a Buy from BTIG
BTIG analyst Ryan Zimmerman maintained a Buy rating on Staar Surgical (STAA – Research Report) today and set a price target of $39.00. The ...
Yahoo Finance3d
STAAR Surgical Company (STAA)
LAKE FOREST, Calif., November 25, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for ...
STAAR Surgical gains amid takeover speculation
STAAR Surgical (NASDAQ:STAA) rose 6.5% amid some takeover speculation. The maker of implantable lenses is said to have been ...
Intelligent Investor1mon
STAAR Surgical Company (NASDAQ: STAA) - Share Price and Research
What is the current share price of STAAR Surgical Company (STAA)? STAAR Surgical Company's (STAA) current share price is $27.72. This constitutes a price movement of 3.90% when compared to the share ...
CNN4y
STAAR Surgical Company
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems.
Wall Street Journal7d
Staar Surgical Co.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...